Mrs Deborah Kay White, PT | |
4250 Hempstead Tpke, Ste 1, Bethpage, NY 11714-5707 | |
(516) 579-7870 | |
(516) 579-7867 |
Full Name | Mrs Deborah Kay White |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 4250 Hempstead Tpke, Bethpage, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396740973 | NPI | - | NPPES |
112807278 | Other | NY | HORIZON HEALTHCARE |
112807278 | Other | NY | HEALTHNET (TRICARE NORTH) |
112807278 | Other | NY | METRACOMP |
112807278 | Other | NY | PHCS |
112807278 | Other | NY | ACCESS MANAGED HEALTHCARE |
3514 | Other | NY | VYTRA HEALTH PLAN |
000000080279 | Other | NY | GHI HMO |
112807278 | Other | NY | MAGNACARE |
4360072 | Other | NY | AETNA HMO |
650013195 | Other | NY | RAILROAD MEDICARE |
112807278 | Other | NY | MULTIPLAN |
112807278 | Other | NY | RISING MEDICAL SOLUTIONS |
ANC1170 | Other | NY | OXFORD HEALTH PLAN |
20089P | Other | NY | HIP |
6600523 | Other | NY | GHI PPO |
934808 | Other | NY | FIRST HEALTH |
Q53971 | Other | NY | BLUSCROSS/BLUESHIELD |
0090294 | Other | NY | AETNA USHC |
373633 | Other | NY | UNITED HEALTHCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 005258-1 (New York) | Primary |
Provider Name | The Weston Group Of South Carolina Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1073957064 PECOS PAC ID: 2062651185 Enrollment ID: O20130621000455 |
News Archive
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Current therapies that target cellular kinases have been effective for some patients: however, many individuals with NSCLS do not respond.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
PolyTherics Limited, a provider of solutions to enable the development of better biopharmaceuticals, and Spirogen Limited, a leading oncology-focused company developing DNA sequence-targeted agents, announce that they have formed a research collaboration to develop antibody drug conjugates that combine PolyTherics' proprietary site-specific conjugation chemistry with Spirogen's highly potent novel cytotoxic drugs to produce novel ADCs for the treatment of cancer.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Deborah Kay White, PT 4250 Hempstead Tpke, Ste 1, Bethpage, NY 11714-5707 Ph: (516) 579-7870 | Mrs Deborah Kay White, PT 4250 Hempstead Tpke, Ste 1, Bethpage, NY 11714-5707 Ph: (516) 579-7870 |
News Archive
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Current therapies that target cellular kinases have been effective for some patients: however, many individuals with NSCLS do not respond.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
PolyTherics Limited, a provider of solutions to enable the development of better biopharmaceuticals, and Spirogen Limited, a leading oncology-focused company developing DNA sequence-targeted agents, announce that they have formed a research collaboration to develop antibody drug conjugates that combine PolyTherics' proprietary site-specific conjugation chemistry with Spirogen's highly potent novel cytotoxic drugs to produce novel ADCs for the treatment of cancer.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
› Verified 9 days ago
Mrs. Jeanann Therese Maguffin, PTMSOCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Park Ave, Bethpage, NY 11714 Phone: 516-939-9859 | |
Farmingdale Physical Therapy West Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4277 Hempstead Tpke Ste 209a, Bethpage, NY 11714 Phone: 516-731-3583 Fax: 516-731-3587 | |
Stephanie Rose Ringbauer, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4277 Hempstead Tpke, Suite 209 A, Bethpage, NY 11714 Phone: 516-731-3583 Fax: 516-731-3587 | |
Jillian Epifania, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4277 Hempstead Tpke, Suite 209 A, Bethpage, NY 11714 Phone: 516-731-3583 Fax: 516-731-3587 | |
Active Mobility Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 59 Martin Rd N, Bethpage, NY 11714 Phone: 516-680-5484 | |
Harveen Kaur Ny Pt, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 316 Hicksville Rd, Bethpage, NY 11714 Phone: 917-679-0029 | |
Ronald Bryan Minear, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4276 Hempstead Tpke, Bethpage, NY 11714 Phone: 516-738-5570 |